<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36183286</PMID><DateCompleted><Year>2023</Year><Month>01</Month><Day>06</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-1459</ISSN><JournalIssue CitedMedium="Internet"><Volume>270</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Journal of neurology</Title><ISOAbbreviation>J Neurol</ISOAbbreviation></Journal><ArticleTitle>Correlation between clinical phenotype and electromyographic parameters in amyotrophic lateral sclerosis.</ArticleTitle><Pagination><StartPage>511</StartPage><EndPage>518</EndPage><MedlinePgn>511-518</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00415-022-11404-4</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Even if electromyography (EMG) is routinely used to confirm the diagnosis of amyotrophic lateral sclerosis (ALS), few studies have analysed the correlation between electrophysiological parameters and clinical characteristics of ALS. We assessed if the quantification of active denervation (AD) and chronic denervation (CD) provides clinicians with information about phenotype, disease progression and survival in ALS patients.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We studied a cohort of 689 ALS patients recording the following parameters: age and site of onset, survival, MRC scale for muscle strength evaluation, burden of upper and lower motor signs as measured with specific scales (PUMNS and LMNS, respectively), ALSFRS-R, progression rate (&#x394;FS), MITOS and King's Staging systems (KSS). We performed EMG on 11 muscles, and calculated semiquantitative AD and CD scores for each limb, as well as for the bulbar and spinal regions.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We found a positive correlation between AD and CD scores with LMNS (respectively p&#x2009;=&#x2009;4.4&#x2009;&#xd7;&#x2009;10<sup>-37</sup> and p&#x2009;=&#x2009;2.8&#x2009;&#xd7;&#x2009;10<sup>-45</sup>) and a negative correlation with MRC (respectively p&#x2009;=&#x2009;4.5&#x2009;&#xd7;&#x2009;10<sup>-35</sup> and p&#x2009;=&#x2009;3.0&#x2009;&#xd7;&#x2009;10<sup>-35</sup>). Furthermore, patients with higher spinal AD and CD scores had significantly lower ALSFRS-R scores, and higher KSS and MITOS stages. Conversely, only AD was associated to higher &#x394;FS (p&#x2009;=&#x2009;1.0&#x2009;&#xd7;&#x2009;10<sup>-6</sup>) and shorter survival (p&#x2009;=&#x2009;1.1&#x2009;&#xd7;&#x2009;10<sup>-5</sup>).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Our results confirmed that EMG examination represents not only a diagnostic instrument, but also a prognostic tool. In this context, AD seems to be a reliable predictor of disease's progression and survival while CD better describes functional disability.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Colombo</LastName><ForeName>Eleonora</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, P.le Brescia 20, 20149, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Doretti</LastName><ForeName>Alberto</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, P.le Brescia 20, 20149, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scheveger</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, P.le Brescia 20, 20149, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neurology Residency Program, Universit&#xe0; degli Studi di Milano, Via Festa del Perdono 7, 20122, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maranzano</LastName><ForeName>Alessio</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, P.le Brescia 20, 20149, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neurology Residency Program, Universit&#xe0; degli Studi di Milano, Via Festa del Perdono 7, 20122, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pata</LastName><ForeName>Giulia</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, P.le Brescia 20, 20149, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gagliardi</LastName><ForeName>Delia</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Neurology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Via Francesco Sforza 35, 20122, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meneri</LastName><ForeName>Megi</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Neurology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Via Francesco Sforza 35, 20122, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathophysiology and Transplantation, Universit&#xe0; degli Studi di Milano, Via Festa del Perdono 7, 20122, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Messina</LastName><ForeName>Stefano</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, P.le Brescia 20, 20149, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Verde</LastName><ForeName>Federico</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, P.le Brescia 20, 20149, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathophysiology and Transplantation, Universit&#xe0; degli Studi di Milano, Via Festa del Perdono 7, 20122, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morelli</LastName><ForeName>Claudia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, P.le Brescia 20, 20149, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Corti</LastName><ForeName>Stefania</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Neurology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Via Francesco Sforza 35, 20122, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathophysiology and Transplantation, Universit&#xe0; degli Studi di Milano, Via Festa del Perdono 7, 20122, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maderna</LastName><ForeName>Luca</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, P.le Brescia 20, 20149, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Silani</LastName><ForeName>Vincenzo</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, P.le Brescia 20, 20149, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathophysiology and Transplantation, Universit&#xe0; degli Studi di Milano, Via Festa del Perdono 7, 20122, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ticozzi</LastName><ForeName>Nicola</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0001-5963-7426</Identifier><AffiliationInfo><Affiliation>Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, P.le Brescia 20, 20149, Milan, Italy. n.ticozzi@auxologico.it.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathophysiology and Transplantation, Universit&#xe0; degli Studi di Milano, Via Festa del Perdono 7, 20122, Milan, Italy. n.ticozzi@auxologico.it.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>10</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>J Neurol</MedlineTA><NlmUniqueID>0423161</NlmUniqueID><ISSNLinking>0340-5354</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>J Neurol. 2023 Jun;270(6):3286-3287</RefSource><PMID Version="1">36913041</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004576" MajorTopicYN="N">Electromyography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Clinical neurophysiology</Keyword><Keyword MajorTopicYN="N">Electromyography</Keyword><Keyword MajorTopicYN="N">Motor neuron disease</Keyword></KeywordList><CoiStatement>E.Colombo, A.Doretti, F. Scheveger, A. Maranzano, G. Pata, D. Gagliardi, M. Meneri, F. Verde, C. Morelli, S. Corti, L. Maderna report no disclosures. S. Messina received compensation for speaking activities from Eli Lilly and Novartis Pharma AG. V. Silani received compensation for consulting services and/or speaking activities from AveXis, Cytokinetics, Italfarmaco, Liquidweb Srl, and Novartis Pharma AG. He is on the Editorial Board of Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, European Neurology, American Journal of Neurodegenerative Diseases, and Frontiers in Neurology. N. Ticozzi received compensation for consulting services from Amylyx Pharmaceuticals and Zambon Biotech SA. He is Associate Editor for Frontiers in Aging Neuroscience.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>7</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>9</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>9</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>10</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>1</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>10</Month><Day>2</Day><Hour>13</Hour><Minute>59</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36183286</ArticleId><ArticleId IdType="doi">10.1007/s00415-022-11404-4</ArticleId><ArticleId IdType="pii">10.1007/s00415-022-11404-4</ArticleId><ArticleId IdType="pmc">PMC9813173</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Brooks BR. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial &#x2018;&#x2018;Clinical limits of amyotrophic lateral sclerosis&#x201d; workshop contributors. J Neurol Sci. 1994;124(Suppl):96&#x2013;107. doi: 10.1016/0022-510X(94)90191-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0022-510X(94)90191-0</ArticleId><ArticleId IdType="pubmed">7807156</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks BR, Miller RG, Swash M, Munsat TL, World Federation of Neurology Research Group on Motor Neuron Diseases El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1(5):293&#x2013;299. doi: 10.1080/146608200300079536.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/146608200300079536</ArticleId><ArticleId IdType="pubmed">11464847</ArticleId></ArticleIdList></Reference><Reference><Citation>De Carvalho M, Dengler R, Eisen A, England JD, Kaji R, Kimura J, Mills K, Mitsumoto H, Nodera H, Shefner J, Swash M. Electrodiagnostic criteria for diagnosis of ALS. Clin Neurophysiol. 2008;119(3):497&#x2013;503. doi: 10.1016/j.clinph.2007.09.1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2007.09.1</ArticleId><ArticleId IdType="pubmed">18164242</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnsen B, Pugdahl K, Fuglsang-Frederiksen A, Kollewe K, Paracka L, Dengler R, Camdessanch&#xe8; JP, Nix W, Liguori R, Schofield I, Maderna L, Czell D, Neuwirth C, Weber M, Drory VE, Abraham A, Swash M, de Carvalho M. Diagnostic criteria for amyotrophic lateral sclerosis: a multicentre study of inter-rater variation and sensitivity. Clin Neurophysiol. 2019;130(2):307&#x2013;314. doi: 10.1016/j.clinph.2018.11.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2018.11.021</ArticleId><ArticleId IdType="pubmed">30573424</ArticleId></ArticleIdList></Reference><Reference><Citation>Gawel M, Kuzma-Kozakiewicz M, Szmidt-Salkowska E, Kaminska A. Are we really closer to improving the diagnostic sensitivity in ALS patients with Awaji criteria? Amyotroph Lateral Scler Frontotemporal Degener. 2014;15:257&#x2013;261. doi: 10.3109/21678421.2014.887118.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2014.887118</ArticleId><ArticleId IdType="pubmed">24575803</ArticleId></ArticleIdList></Reference><Reference><Citation>de Carvalho M, Swash M. Awaji diagnostic algorithm increases sensitivity of El Escorial criteria for ALS diagnosis. Amyotroph Lateral Scler. 2009;10(1):53&#x2013;57. doi: 10.1080/17482960802521126.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17482960802521126</ArticleId><ArticleId IdType="pubmed">18985466</ArticleId></ArticleIdList></Reference><Reference><Citation>Li D, Liu M, Cui B, Fang J, Guan Y, Ding Q, et al. The Awaji criteria increases the diagnostic sensitivity of the revised El Escorial criteria for amyotrophic lateral sclerosis diagnosis in a Chinese population. PLoS ONE. 2017;12(3):e171522.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5332033</ArticleId><ArticleId IdType="pubmed">28249004</ArticleId></ArticleIdList></Reference><Reference><Citation>Boekestein WA, Kleine BU, Hageman G, Schelhaas HJ, Zwarts MJ. Sensitivity and specificity of the &#x2018;Awaji&#x2019; electrodiagnostic criteria for amyotrophic lateral sclerosis: retrospective comparison of the Awaji and revised El Escorial criteria for ALS. Amyotroph Lateral Scler. 2010;11(6):497&#x2013;501. doi: 10.3109/17482961003777462.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482961003777462</ArticleId><ArticleId IdType="pubmed">20536375</ArticleId></ArticleIdList></Reference><Reference><Citation>Schrooten M, Smetcoren C, Robberecht W, Van Damme P. Benefit of the Awaji diagnostic algorithm for amyotrophic lateral sclerosis: a prospective study. Ann Neurol. 2011;70(1):79&#x2013;83. doi: 10.1002/ana.22380.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.22380</ArticleId><ArticleId IdType="pubmed">21437935</ArticleId></ArticleIdList></Reference><Reference><Citation>Shefner JM, Al-Chalabi A, Baker MR, Cui L-Y, de Carvalho M, Eisen A, Grosskreutz J, Hardiman O, Henderson R, Matamala JM, Mitsumoto H, Paulus W, Simon N, Swash M, Talbot K, Turner MR, Ugawa Y, van den Berg LH, Verdugo R, Vucic S, Kaji R, Burke D, Kiernan MC. A proposal for new diagnostic criteria for ALS. Clin Neurophysiol. 2020;131(8):1975&#x2013;1978. doi: 10.1016/j.clinph.2020.04.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2020.04.005</ArticleId><ArticleId IdType="pubmed">32387049</ArticleId></ArticleIdList></Reference><Reference><Citation>Krarup C. Lower motor neuron involvement examined by quantitative electromyography in amyotrophic lateral sclerosis. Clin Neurophysiol. 2011;122(2):414&#x2013;422. doi: 10.1016/j.clinph.2010.06.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2010.06.027</ArticleId><ArticleId IdType="pubmed">20659815</ArticleId></ArticleIdList></Reference><Reference><Citation>Sato Y, Nakatani E, Yasuhiro Watanabe Y, Fukushima M, Nakashima K, Kannagi M, Kanatani Y, Mizushima H. Prediction of prognosis of ALS: importance of active denervation findings of the cervical-upper limb area and trunk area. Intractable Rare Dis Res. 2015;4(4):181&#x2013;189. doi: 10.5582/irdr.2015.01043.</Citation><ArticleIdList><ArticleId IdType="doi">10.5582/irdr.2015.01043</ArticleId><ArticleId IdType="pmc">PMC4660859</ArticleId><ArticleId IdType="pubmed">26668778</ArticleId></ArticleIdList></Reference><Reference><Citation>Fileccia E, De Pasqua S, Rizzo G, Di Stasi V, Vacchiano V, Avoni P, Bartolomei I, Pastorelli F, Plasmati R, Donadio V, Salvi F, Liguori R. Denervation findings on EMG in amyotrophic lateral sclerosis and correlation with prognostic milestones: data from a retrospective study. Clin Neurophysiol. 2020;131(8):2017&#x2013;2022. doi: 10.1016/j.clinph.2020.04.161.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2020.04.161</ArticleId><ArticleId IdType="pubmed">32507653</ArticleId></ArticleIdList></Reference><Reference><Citation>Vacchiano V, Di Stasi V, Rizzo G, Giannoccaro MP, Donadio V, Bartolomei I, Capellari S, Salvi F, Avoni P, Rocco LR. Prognostic value of EMG genioglossus involvement in amyotrophic lateral sclerosis. Clin Neurophysiol. 2021;132(10):2416&#x2013;2421. doi: 10.1016/j.clinph.2021.07.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2021.07.011</ArticleId><ArticleId IdType="pubmed">34454268</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang HG, Zhang S, Xu YS, Zhang N, Fan DS. Association between rectus abdominis denervation and ventilation dysfunction in patients with amyotrophic lateral sclerosis. Chin Med J (Engl) 2016;129(17):2063&#x2013;2066. doi: 10.4103/0366-6999,189070.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0366-6999,189070</ArticleId><ArticleId IdType="pmc">PMC5009589</ArticleId><ArticleId IdType="pubmed">27569232</ArticleId></ArticleIdList></Reference><Reference><Citation>Reniers W, Schrooten M, Claeys KG, Tilkin P, D&#x2019;Hondt A, Van Reijen D, Couwelier G, Lamaire N, Robberecht W, Fieuws S, Van Damme P. Prognostic value of clinical and electrodiagnostic parameters at time of diagnosis in patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotempor Degener. 2017 doi: 10.1080/21678421.2017.1288254.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2017.1288254</ArticleId><ArticleId IdType="pubmed">28631957</ArticleId></ArticleIdList></Reference><Reference><Citation>Vucic S, Rutkovec SB. Neurophysiological biomarkers in amyotrophic lateral sclerosis. Curr Opin Neurol. 2018;31(5):640&#x2013;647. doi: 10.1097/WCO.0000000000000593.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WCO.0000000000000593</ArticleId><ArticleId IdType="pubmed">30080715</ArticleId></ArticleIdList></Reference><Reference><Citation>Sleutjes BTHM, Maathuis EM, van Doorn PA, Blok JH, Visser GH. Electrically evoked multiplet discharges are associated with more marked clinical deterioration in motor neuron disease. Muscle Nerve. 2016;53:222&#x2013;226. doi: 10.1002/mus.24700.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.24700</ArticleId><ArticleId IdType="pubmed">25960042</ArticleId></ArticleIdList></Reference><Reference><Citation>van Dijk JP, Schelhaas HJ, van Schaik IN, Janssen HM, Stegeman DF, Zwarts MJ. Monitoring disease progression using high-density motor unit number estimation in amyotrophic lateral sclerosis. Muscle Nerve. 2010;42:239&#x2013;244. doi: 10.1002/mus.21680.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.21680</ArticleId><ArticleId IdType="pubmed">20544934</ArticleId></ArticleIdList></Reference><Reference><Citation>de Carvalho M, Swash M. Sensitivity of electrophysiological tests for upper and lower motor neuron dysfunction in ALS: a six-month longitudinal study. Muscle Nerve. 2010;41(2):208&#x2013;211.</Citation><ArticleIdList><ArticleId IdType="pubmed">19697379</ArticleId></ArticleIdList></Reference><Reference><Citation>Devine MS, Ballard E, O&#x2019;Rourke P, Kiernan MC, Mccombe PA, Henderson RD. Targeted assessment of lower motor neuron burden is associated with survival in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2016;17(3&#x2013;4):184&#x2013;190. doi: 10.3109/21678421.2015.1125502.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2015.1125502</ArticleId><ArticleId IdType="pubmed">26700804</ArticleId></ArticleIdList></Reference><Reference><Citation>Quinn C, Edmundson C, Dahodwala N, Elman L. Reliable and efficient scale to assess upper motor neuron disease burden in amyotrophic lateral sclerosis. Muscle Nerve. 2020;61(4):508&#x2013;511. doi: 10.1002/mus.26764.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.26764</ArticleId><ArticleId IdType="pubmed">31743477</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>